FYCOMPA Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
FYCOMPA General Information
Description
Developer of epilepsy medicine intended to serve patients aged 4 and older. The company offers to treat partial-onset seizures with or without secondarily generalized seizures.
Contact Information
Website
www.fycompa.comOwnership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
- United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
- United States
FYCOMPA Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
FYCOMPA Patents
FYCOMPA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D540408-S1 | Basketball | Inactive | 03-May-2006 |
FYCOMPA Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
FYCOMPA FAQs
-
Where is FYCOMPA headquartered?
FYCOMPA is headquartered in .
-
What industry is FYCOMPA in?
FYCOMPA’s primary industry is Drug Discovery.
-
Is FYCOMPA a private or public company?
FYCOMPA is a Private company.
-
What is the current valuation of FYCOMPA?
The current valuation of FYCOMPA is .
-
What is FYCOMPA’s current revenue?
The current revenue for FYCOMPA is .
-
Who are FYCOMPA’s investors?
Eisai has invested in FYCOMPA.
-
When was FYCOMPA acquired?
FYCOMPA was acquired on 24-Jan-2023.
-
Who acquired FYCOMPA?
FYCOMPA was acquired by Catalyst Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process